As part of its ongoing charity programmes, Arterium has donated laryngoscopy equipment kits to five Ukrainian hospitals. These kits are used in the treatment of patients with severe coronavirus symptoms before intubation for mechanical ventilation.These hospitals have special support units providing medical care for patients with coronavirus.

The Arterium Corporation has introduced a new product for veterinary medicine: Relania. This drug is an analgesic that belongs to the group of synthetic opioids. The use of Relania in combination with anaesthetics can reduce acute pain, which prevents the development of chronic pain syndrome, thereby speeding up the recovery of animals after surgery. The uniqueness of the drug is its active substance Butorphanol which is one of the most powerful analgesics used in veterinary practice.

As a part of its ongoing charity programme aimed at combating the spread of coronavirus infection COVID-19, the Arterium Corporation has donated a bronchoscope to the 8th Lviv city clinical hospital.

Recognising the importance of coordinated action and mutual responsibility for the health of Ukrainians, Arterium continues to help doctors in line with previous commitments. 

As part of the activities of a charity fund created to combat the spread of the COVID-19 infection, Arterium has provided a low-temperature medical freezer to the Kyiv Laboratory Centre of the Ministry of Health of Ukraine. More than 500 samples for coronavirus tests from Kyiv and the Kyiv Region are submitted to the laboratory daily. The freezer allows for the storage of samples at temperatures down to -86C, which increases the storage capacity of the analysed samples of nucleic acids, tissues, cells and also allows for the storage of biomaterials, reagents and test systems for PCR diagnostics.

The Arterium Corporation has introduced a product to prevent corneal edema: Terso drops. This product is designed and manufactured by the Italian pharmaceutical company DMG Italia srl. The company specialises in the production of innovative medicines, medical devices and dietary supplements. According to WHO statistics, one in ten patients with ophthalmic problems suffers from corneal edema.